Message delivered: how myocytes control cAMP signaling.

See related article, pages 1091–1100 Despite the vast array of specific receptors and ligands through which cells receive information from their outside environment, the first line of messengers that relay this onto internal signaling cascades is more limited. Yet, somehow, the purpose of the original message is conveyed (ie, we know who knocked on the front door), and the message ends up influencing just the right proteins to produce the desired effect. A striking example of this selectivity is the cyclic nucleotides for which only 2 basic types exist; cAMP and cGMP. Despite this limited cast, these molecules precisely regulate many complex and disparate cellular activities. Their trick is to be in the right place at the right time and with the right amount of signal. It is now well established that cyclic nucleotides are spatially compartmentalized to enable different external triggers to vary the internal cellular response.1–5 This can be achieved by localizing the cyclases that synthesize cAMP or cGMP in different parts of the cell, parking the effector kinase protein kinase (PK)A in particular regions by means of anchoring proteins (AKAPs)6 (may apply to PKG though still unclear), and targeting phosphodiesterases to one area or another and/or providing them with hierarchical control.1 The latter is thought to be particularly important by limiting diffusion of a cyclic nucleotide from its site of generation to other parts of the cell. There are eleven 3′,5′-phosphodiesterase (PDE) subfamily members with approximately 50 isoforms, targeting cAMP, cGMP, or in some instances both.7 Given that many of these PDEs can themselves be activated by cyclic nucleotides and/or their effector kinases, the system has substantial built-in complexity for localized regulation. Compartmental signaling was first …

[1]  Rodolphe Fischmeister,et al.  Spatiotemporal Dynamics of β-Adrenergic cAMP Signals and L-Type Ca2+ Channel Regulation in Adult Rat Ventricular Myocytes: Role of Phosphodiesterases , 2008, Circulation research.

[2]  A. Bonev,et al.  Differential patterning of cGMP in vascular smooth muscle cells revealed by single GFP-linked biosensors , 2008, Proceedings of the National Academy of Sciences.

[3]  P. Backx,et al.  PI3K&ggr; Is Required for PDE4, not PDE3, Activity in Subcellular Microdomains Containing the Sarcoplasmic Reticular Calcium ATPase in Cardiomyocytes , 2007, Circulation research.

[4]  J. Beavo,et al.  Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. , 2007, Annual review of biochemistry.

[5]  D. Kass,et al.  Compartmentalization of Cardiac &bgr;-Adrenergic Inotropy Modulation by Phosphodiesterase Type 5 , 2007 .

[6]  G. Baillie,et al.  cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. , 2007, Circulation research.

[7]  O. Osadchii Myocardial Phosphodiesterases and Regulation of Cardiac Contractility in Health and Cardiac Disease , 2007, Cardiovascular Drugs and Therapy.

[8]  M. Lohse,et al.  Cyclic AMP Imaging in Adult Cardiac Myocytes Reveals Far-Reaching &bgr;1-Adrenergic but Locally Confined &bgr;2-Adrenergic Receptor–Mediated Signaling , 2006, Circulation research.

[9]  M. Hori,et al.  Acute heart failure: inotropic agents and their clinical uses , 2006, Expert opinion on pharmacotherapy.

[10]  R. Fischmeister,et al.  Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. , 2006, Circulation research.

[11]  M. Silberbach,et al.  Natriuretic Peptides and Nitric Oxide Stimulate cGMP Synthesis in Different Cellular Compartments , 2006, The Journal of general physiology.

[12]  D. Cooper,et al.  Cyclic Guanosine Monophosphate Compartmentation in Rat Cardiac Myocytes , 2006, Circulation.

[13]  L. Langeberg,et al.  Compartmentation of Cyclic Nucleotide Signaling in the Heart The Role of A-Kinase Anchoring Proteins , 2006 .

[14]  D. Cooper,et al.  A Specific Pattern of Phosphodiesterases Controls the cAMP Signals Generated by Different Gs-Coupled Receptors in Adult Rat Ventricular Myocytes , 2006, Circulation research.

[15]  M. Zaccolo,et al.  Compartmentalized Phosphodiesterase-2 Activity Blunts &bgr;-Adrenergic Cardiac Inotropy via an NO/cGMP-Dependent Pathway , 2006, Circulation research.

[16]  Stepan Gambaryan,et al.  Fluorescent sensors for rapid monitoring of intracellular cGMP , 2005, Nature Methods.

[17]  Xiaodong Cheng,et al.  Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Tullio Pozzan,et al.  Discrete Microdomains with High Concentration of cAMP in Stimulated Rat Neonatal Cardiac Myocytes , 2002, Science.

[19]  R Y Tsien,et al.  Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Hosoda,et al.  Contribution of phosphodiesterase isozymes to the regulation of the L‐type calcium current in human cardiac myocytes , 1997, British journal of pharmacology.

[21]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.